Lipozene

April 2018: The Ninth Circuit Court of Appeals denied the plaintiff’s request for mandamus relief to reverse the order transferring the case. (Case No. 17-70614, 9th Cir.)

April 2017: The appeal was dismissed for lack of jurisdiction. (Case No. 17-55135, 9th Cir.)

March 2017: Plaintiffs filed a Petition for a Writ of Mandamus that would reverse the district court’s January 2017 transfer order.

February 2017: Plaintiffs filed a Notice of Appeal regarding the January 2017 transfer order.

January 2017: This case was transferred to another California court in order to be consolidated with Fernandez v. Obesity Research Institute.

March 2016: A class-action lawsuit was filed against Obesity Research Institute and others for allegedly falsely advertising the weight-loss supplement Lipozene as clinically proven to help users lose weight without exercising or changing their diet. The complaint also alleges, among other things, that the marketing violates a 2005 Court Order that permanently prohibits Obesity Research Institute and others from making certain claims in the marketing for products. (Bozic et al v. Obesity Research Institute, Case No. 16-cv-733, S. D. CA.)

For more information about other class-action lawsuits regarding Lipozene and TINA.org’s coverage of the product, click here.

Print Friendly, PDF & Email

Tags: , ,



One Response to Lipozene

  1. Doug T. says:

    How do I ad myself to this lawsuit including libel & Defamation of character on credit reporting?

Leave a Reply

Back to Top ↑
  • Search Class-Action Tracker



  • Recent Class Actions

  • The Class-Action Tracker is intended to notify consumers about false advertising class-action lawsuits filed around the country, but does not necessarily reflect TINA.org’s opinion with respect to the lawsuits or disposition of the cases

  • Sign Up for E-mail Updates